Navigation Links
Mayo-led researchers discover genetic variants modifying breast cancer risk
Date:9/19/2010

ROCHESTER, Minn. -- Individuals with disrupting mutations in the BRCA1 gene are known to be at substantially increased risk of breast cancer throughout their lives. Now, discoveries from an international research team led by Mayo Clinic researchers show that some of those persons may possess additional genetic variants that modify their risk. These new findings enhancing individualized medicine appear in the current Nature Genetics.

"These findings should be useful in helping determine individual risk for breast cancer in BRCA1 carriers," says Fergus Couch, Ph.D., Mayo investigator and senior author of the study. "It also provides insights into hormone-receptor-negative breast cancer in the general population."

Genetic mutations in the BRCA1 gene give carriers of these mutations an increased risk for developing breast cancer. To determine if any genetic variations would modify or alter this risk among large populations of the mutation carriers, the researchers conducted genome-wide association studies (GWAS) that ultimately spanned 20 research centers in 11 different countries.

They first studied 550,000 genetic alterations from across the human genome in 1,193 carriers of BRCA1 mutations under age 40 who had invasive breast cancer and compared the alterations to those in 1,190 BRCA1 carriers of similar age without breast cancer. The 96 single nucleotide polymorphisms (SNPs) discovered were subsequently studied in a larger sample population of roughly 3,000 BRCA1 carriers with breast cancer and 3,000 carriers without cancer. Researchers found five SNPs associated with breast cancer risk in a region of chromosome 19p13.

Further studies of those SNPs in 6,800 breast cancer patients without BRCA1 mutations showed associations with estrogen-receptor-negative disease, meaning cancer in which tumors don't possess estrogen receptors. In another GWAS involving 2,300 patients, the five SNPs also were associated with triple-negative breast cancer, an aggressive form of the disease accounting for about 12 percent of all breast cancer. Triple-negative tumors don't express genes for estrogen or progesterone receptors or Her2/neu. The researchers also found that these SNPs were not related to risk for ovarian cancer in BRCA1 mutations carriers.

By locating these risk-modifying SNPs, the researchers have provided a target for better understanding the mechanisms behind the development of breast cancer. Furthermore, when combined with other risk-modifying SNPs that remain to be identified in ongoing studies by this group, it may be possible to identify certain BRCA1 carriers who are at lower risk of cancer and, also, carriers at particularly elevated risk of cancer who may decide to change their approach to cancer prevention.


'/>"/>

Contact: Robert Nellis
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Mayo-led research team develop agents that keep insulin working longer
2. Rutgers researchers discover how HIV resists AZT
3. Researchers at SUNY Downstate find drug combination may treat traumatic brain injury
4. Do the math, say UCLA researchers
5. MIT researchers discover an unexpected twist in cancer metabolism
6. OHSU researchers able to determine brain maturity through analyzing MRI scans
7. Lung cancer culprit could offer target for therapy, UT Southwestern researchers report
8. Researchers Develop Touch-Sensitive e-Skin
9. NYU researchers identify new neurological deficit behind lazy eye
10. SWOG names 5 cancer researchers outstanding Young Investigators
11. Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... Va. (PRWEB) , ... April 28, 2016 , ... ... Angeles was among the organization’s most successful events, attracting medical professionals from around ... courses, and stimulating networking events. , Opening Ceremonies Sunday, April 17 included the ...
(Date:4/28/2016)... MA (PRWEB) , ... April 28, 2016 , ... In ... revolutionary work in the emerging field of biomechatronics, technology that marries human physiology with ... MIT Media Lab. He is also the Founder of BionX , a leader ...
(Date:4/28/2016)... ... April 28, 2016 , ... Amada Senior Care, premier provider of ... San Antonio – its San Antonio West location. Prior to entering the senior care ... The grand opening of Amada San Antonio West will take place on Friday, April ...
(Date:4/28/2016)... MA (PRWEB) , ... April 28, 2016 , ... A ... were typical among 18 states studied, the Workers Compensation Research Institute (WCRI) ... The WCRI study, CompScope™ Benchmarks for Kentucky, 16th Edition , found that indemnity ...
(Date:4/28/2016)... ... 2016 , ... Starting today, households across the United States ... Prescription Assistance Program. They are customized to reflect the specific health needs of ... ready-to-use, state-themed card and, in the near future, material that highlights savings on ...
Breaking Medicine News(10 mins):
(Date:4/26/2016)... April 26, 2016 US demand for ... expand 4.9 percent annually to $27.6 billion in ... facilities to decrease rates of healthcare-associated infections (HAIs) ... equipment, and services.  Although declining, the overall rate ... targeted levels set by the CDC.  Recent statistics ...
(Date:4/26/2016)... 2016 Bayer AG has reported ... depreciation and amortization. The earnings are the result of ... drugs Xarelto and Eylea, drugs Bayer is banking on ... expiration date was extended by four years this week ... expected to reach a value of USD 1,147.1 ...
(Date:4/26/2016)... 2016 According to ... Size, Share, Development, Growth and Demand Forecast ... (Consumables, Instruments and Software and Services), by ... Application (Diagnostic Application, Food and Beverage Testing, ... End User (Hospitals, Pharmaceutical & Biotech Companies, ...
Breaking Medicine Technology: